Search
Zentalis Pharmaceuticals Inc
ZNTLAdd to Watchlist
4.740USD
-0.180-3.66%
Close 07-31 16:00（ET）Quotes delayed by 15 min
337.42MMarket Cap
LossP/E TTM
Zentalis Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Zentalis Pharmaceuticals Inc is 7.38, ranking 178 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.73, which is -87.90% below the recent high of -0.33 and -159.61% above the recent low of -7.09.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.